PhRMA loses GOP lobbyist
Executive Summary
Pharmaceutical Research & Manufacturers of America Senior Director-Federal Affairs Missy Jenkins is leaving the trade association after two years. Jenkins, whose Capitol Hill experience includes serving on the staff of former Rep. Newt Gingrich (R-Ga.) and former Sen. Alan Simpson (R-Wyo.), is understood to have resigned from PhRMA on June 6. Two other members of PhRMA's federal affairs team left earlier this year to join member companies. Sonya Sotak (formerly a staffer to Sen. John McCain) joined the Lilly D.C. office, while Jacqueline Pomfret (formerly with AAHP) joined AstraZeneca (1"The Pink Sheet" May 12, 2003, p. 32)...
You may also be interested in...
PCMA federal affairs
Missy Jenkins joins Pharmaceutical Care Management Association as VP-federal affairs. Jenkins was previously with the Pharmaceutical Research & Manufacturers of America's lobbying team (1"The Pink Sheet" June 16, 2003, In Brief). PCMA has revamped its public affairs and lobbying staffs and taken a more aggressive stance on Capitol Hill since Mark Merritt became CEO in March ("The Pink Sheet" May 19, 2003, p. 29). Merritt also moved to PCMA from PhRMA...
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.